BioSpace News Archive

Increasing consciousness among individuals to enhance their aesthetic appearance is stimulating demand for cosmetic facial enhancement procedures, fueling future growth

BioArctic AB announced that the company and its collaboration partner Eisai will both present data relating to its investigational anti-amyloid beta protofibril antibody lecanemab, at the 15th International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, AD/PD™ 2021.

Increasing demand for improving patient outcomes and reducing surgery time is accelerating automated solutions adoption, thus propelling the market forward

The first synthesis of an artificial gene dates back to 1970, achieved by Nobel Prize winner Har Gobind Khorana.

End-stage renal disease is a major health issue affecting millions of people around the world. The incidence of chronic kidney diseases is increasing at a higher rate in emerging countries owing to sedentary lifestyles, increasing incidence of diabetes among the general population, and higher prevalence of hypertension.

Eye is the most accessible organ in the human body. Due to this feature, ophthalmic diagnostics agents play a significant role in ophthalmology to aid effective diagnosis of an ocular condition.

Retina is the third-inner layer of the eye, responsible for light and color detection. Retinoblastoma is a rare type of cancer which develops in the retina, particularly in children.

Microalbuminuria is a condition that affects the kidney and restricts in retaining serum albumin, which is considered as a vital factor for the kidney to maintain its overall health of the body.

The brain mapping research along with the investigation projects, as well as the technological developments in tools and algorithms that are being implemented in neuroscience space are among the primary factors contributing to the progress of the global neuroscience market.

The global RNAi Technology Market is on a trajectory that will take the market worth up to an impressive figure by the end of the forecast period of 2018 to 2028, thanks to a steady growth rate, compounded annually, accelerating the growth momentum.